Core Insights - The company held an online performance briefing on September 17, 2025, with active participation from investors discussing business development and market trends [1][2] Business and Market Development Highlights - The global high-value medical consumables market is projected to reach $347.8 billion by 2031, with a compound annual growth rate (CAGR) of 8.4% from 2025 to 2031. Despite challenges such as rising raw material prices, product innovation remains a core focus. In China, factors like an aging population will drive demand for high-value medical consumables, indicating a broad market potential [3] Logistics and Supply Chain Advantages - As of June 30, 2025, the company operates 111 branches and subsidiaries across 31 provinces, cities, and autonomous regions in China. Its 2-hour delivery radius covers over 80% of tertiary hospitals nationwide, achieving 80,000 surgical setups in the first half of 2025. The establishment of 9 third-party warehouses in 8 cities enhances supply chain efficiency [4] Information Technology Leadership - The company has developed a mature information system utilizing cloud computing, featuring four supporting middle-platform architectures. It has independently developed core operational modules for business visibility and traceability, meeting various stakeholder needs. Additionally, the company collaborates with regulatory bodies to promote compliance in the industry [5] "JuXieTong" Initiative - The "JuXieTong" platform provides channel marketing and comprehensive supply chain solutions for manufacturers, addressing challenges such as recruitment difficulties. It supports fully automated business scenarios and leverages new internet technologies to create standardized business middle platforms, enhancing supply chain efficiency [6] Financial Performance in H1 2025 - In the face of market changes, the company optimized its product structure, achieving revenue of 3.679 billion yuan, a slight increase of 0.54% year-on-year. Net profit reached 52.1 million yuan, with net cash flow from operating activities amounting to 387 million yuan, reflecting a year-on-year growth of 11.21%. The company demonstrates a strong development trend in the high-value medical consumables market, supported by advantages in logistics and information technology [7]
调研速递|国科恒泰接受线上投资者调研，聚焦高值耗材市场与业务亮点